Abiopharma

News list

Director Grissinger Michael 🟢 acquired 2.0K shares (1 derivative) of Lipocine Inc. (LPCN) at $2.11 Transaction Date: Aug 03, 2026 | Filing ID: 036577

Full text

News bot Aug. 7, 2026, 8:12 p.m.
🔍 Grissinger Michael (Director)

Company: Lipocine Inc. (LPCN)

Report Date: 2026-08-03
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,000
Detailed Transactions and Holdings:
- Acquired 2,000 shares of Stock Option (Right to Buy) at $2.11 per share (Derivative)
  Date: 2026-08-03 | Code: A | Expires: 2036-08-03 | Exercise: 2027-08-03 | equity_swap_involved: 0 | shares_owned_after: 2,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.